6 ways to overcome Imposter Syndrome
"I can't believe I got the job, they must be desperate."
"I'm not good enough."
"I wasn't very good. They will realise soon and get rid of me."
"I don't think I know what I am talking about."
Local health and care champion seeks new leader
Healthwatch Cambridgeshire and Peterborough CIC are on the hunt for a new CEO after leader, Sandie Smith, announces she will be stepping down in March 2023, after ten years at the helm.
Optibrium expands operations in North America for AI and computational drug discovery technologies
CAMBRIDGE, UK and CAMBRIDGE, US – Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, announces the opening of its US subsidiary, Optibrium Inc., and the promotion of Dr Tamsin Mansley to President of the new subsidiary to lead its US-based team and business operations.
October update from Guardtech - aiming to end a prosperous year on a high
Suffolk-based cleanroom construction company ready for final push in remaining months of busiest ever year.
Dr Thanos Papathanasiou becomes CEO at world-renowned Bourn Hall IVF Clinic
Dr Thanos Papathanasiou, Medical Director at Bourn Hall, the world’s first IVF clinic, has been appointed its new CEO, succeeding Dr Mike Macnamee.
Best practices for measuring dew point in transmission gas
Protecting pipelines and gas power systems
Pure shortlisted for two Investors In People Awards
The Pure team are really pleased to announce that it has made the final shortlists for two awards at the Investors in People Awards 2022. With entries from over three hundred organisations – a record-breaking year – this is an amazing achievement.
Incident Response Plans - how to prepare for a cyber attack
Barnes Commercial Insurance Broker says - read our advice on how to form an effective incident response plan to protect your business and its data in the event of a cyber attack.
Mission Street and BGO plot new Cambridge science district
Partners have purchased a 23 acre site for their lab space joint venture
Free spaces available on Evolve Workplace Wellbeing Network
Evolve Workplace Wellbeing have a number of free places available for the first group to join their new online Evolve Workplace Wellbeing network: a chance for like-minded managers, HR practitioners and business leaders to hear cutting-edge insight into workplace wellbeing (from our research) and
Biocair announces event to advise on building a resilient supply chain
Biocair is aiming to educate Contract Manufacturing Organisations (CMOs) and pharmaceutical sponsors on the value of lane risk assessments ahead of shipping Active Pharmaceutical Ingredients (APIs) and finished drug products globally.
New headline results from Phase I clinical trial of ultra-rapid acting insulin candidate AT247
Cambridge UK - Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces headline results from the second Phase I clinical trial of its ultra-rapid acting insulin, AT247, which support its potential to facilitate a fully closed loop artificial pancreas.
Sensors in Medicine 2022 - just 4 weeks away
The 10th Annual Sensors in Medicine 2022 conference takes place online from 8 - 11 November. Each session is held from 2:00pm to 6:00pm (GMT) daily. Technical sessions are on: Sweat analysis; Molecular sensors; Wearable sensors; Sensors for infectious diseases; the Future of Sensors.
Bittersweet Celebration at the Ex-Forces in Business Awards
John Dibb says - attending the Ex-Forces in Business Awards last month was an incredible celebration. The tributes to those with military careers and forging new ones was an honour to witness, and it was an even bigger honour to have been shortlisted myself for Entrepreneur of the Year.
Introducing Projection Micro Stereolithography (PµSL)
Prototype Projects says - we're really excited to make a BIG announcement about a new 3D Printing process that makes teeny tiny parts which are incredibly accurate. Introducing... Projection Micro Stereolithography, or PµSL, an exciting additive manufacturing technology for building parts that cannot be produced using other technologies such as conventional SLA, DLP, SLS or PolyJet.
Part 2: Low-priced oncology disruptors - The cuckoo in the PD-1/PD-L1 nest or the runt of the clutch?
Part II of this article was originally published in PharmaPhorum.
Stephen Galt, formerly of Fishawack Health, joins Cambridge Healthcare Research as Chief Commercial Officer
Cambridge, England - Stephen Galt has been appointed as Chief Commercial Officer by the Board of Directors at Cambridge Healthcare Research (CHR) to support the business through its next period of growth.
Lab Hotel at Stevenage Bioscience Catalyst now fully booked
Stevenage Bioscience Catalyst (SBC) has awarded space in its Lab Hotel to start-ups Neobe Therapeutics and Genenet Technology. The Lab Hotel is a unique facility offering free lab and office accommodation for six months.
Optibrium strengthens global AI drug discovery software operations with three key appointments
Cambridge, UK - Optibrium, a leading developer of software and artificial intelligence (AI) solutions for drug discovery, announces three key appointments: Michelle Harrison as Head of Strategic Marketing, Chris Khoury as Associate Director of Business Development, and Imran Ghauri as Business Development Manager.
Part 1: Low-priced oncology disruptors - The cuckoo in the PD-1/PD-L1 nest or the runt of the clutch?
Part I of this article was originally published in PharmaPhorum.
Cresset's September 2022 Newsletter
Introducing Hit Expander and a sneak peek at Flare V6.1; molecular modeling to deliver corporate objectives
How far do you want to go with workplace wellbeing?
Calling managers and leaders of UK organisations (public, private and third sector organisations all welcome!) to give their opinions on workplace wellbeing initiatives.
Astrea Bioseparations introduces Nereus LentiHERO, a fit-for-purpose solution for lentiviral vector purification
Cambridge, UK - Astrea Bioseparations, a leading provider of novel purification and separation tools supporting the development of next-generation therapeutics, announces the commercial launch of its Nereus LentiHERO™ lentiviral vector (LVV) purification technology.
Innovation influencers to host definitive ‘Cambridge tech’ podcast
An authoritative new podcast dedicated to ‘all things Cambridge Tech’ aims to become the definitive ‘tech talk show’ for Cambridge’s exciting innovation ecosystem.
Yourgene Health Receives HSA approval for IONA Nx NIPT Workflow in Singapore
Manchester, UK - Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, announces it has received Health Sciences Authority (HSA) approval for its IONA® Nx NIPT Workflow in Singapore.